Skip to content
OpenCapital
Get started

Caribou Biosciences, Inc. CRBU Q1 2026 earnings

Reported May 7, 2026 · Before market open

Revenue$2.4MBeat by $184.4K
EPS-$0.26Beat by $0.07
Revenue estimate$2.2M
EPS estimate-$0.33

Next report

Aug 12, 2026 (In 2 weeks)
Revenue estimate$2.3M
EPS estimate-$0.33

Versus estimates

Revenue

Q1 2026$2.4MBeat by $184.4K
Q4 2025$3.9MBeat by $1.7MQ3 2025$2.2MBeat by $241.0KQ2 2025$2.7MBeat by $1.1MQ1 2025$2.4MBeat by $501.6KQ4 2024$2.1MMiss by $29.3K

Diluted EPS

Q1 2026-$0.26Beat by $0.07
Q4 2025-$0.28Beat by $0.05Q3 2025-$0.30Beat by $0.06Q2 2025-$0.35Beat by $0.05Q1 2025-$0.43In lineQ4 2024-$0.39Beat by $0.01

Ask the moment Caribou Biosciences, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Caribou Biosciences, Inc. report Q1 2026 earnings?
Caribou Biosciences, Inc. (CRBU) reported Q1 2026 earnings on May 7, 2026 before market open.
What were Caribou Biosciences, Inc.'s Q1 2026 revenue and EPS?
Caribou Biosciences, Inc. reported revenue of $2.4M and eps of $-0.26 for Q1 2026.
Did Caribou Biosciences, Inc. beat estimates in Q1 2026?
Revenue beat the consensus estimate of $2.2M by $184.4K. EPS beat the consensus estimate of $-0.33 by $0.07.
How did Caribou Biosciences, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 1.9% from $2.4M a year earlier and eps grew 39.5% from $-0.43.
Where can I find Caribou Biosciences, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001619856-26-000035) and the 10-Q periodic report (0001619856-26-000036) directly on SEC EDGAR. The filing index links above go to sec.gov.